Patent · US Active

Prognosis and therapy of liver failure

US8415117B2 · kind B2 · utility

0Cited by

2References

11Claims

0Family size

Assignee

UCL BUSINESS PLC · GB

Inventors

Rajiv Jalan · London, GB
Rajeshwar Prosad Mookerjee · London, GB
Vanessa Stadlbauer · London, GB
Nathan Davies · London, GB

Key dates

Filing date	Oct 29, 2007
Grant date	Apr 9, 2013
Priority date	—
Expiry date	Oct 29, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A90/10
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A method for assessing prognosis in an individual suffering from liver failure, which method comprises detecting endotoxin in the individual, for example by determining the neutrophil function in the individual. The method can be used to determine whether there is an increased risk of infection in the individual, an increased risk of organ failure in the individual, an increased risk of mortality in the individual and/or an increased risk that the individual will not respond positively to treatment with an immunosuppressive agent, a steroid or an antibiotic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.